dr. robert griffin specializes in pain management. >> it takes a long time to really know all of the longm effect and really, to prove that something has no risk of addiction over time. >> do you see this -- your concept as, part of the solution to combatting the epidemic? absolutely. a lot of us are in pain. if we don't give painkillers we'll never solve the problem. >> blue therapeutics says it could be five years before the drugmakers it through clinical trials to see if they confirm its claims. kenneth craig, cbs news, cambridge, massachusetts. >>> up next, how a horse named justify made history. when you humble yourself under the mighty hand of god, in due time he will exalt you. hi, i'm joel osteen. i'm excited about being with you every week. i hope you'll tune in. you'll be inspired, you'll be encouraged. i'm looking forward to seeing you right here. you are fully loaded and completely equipped for the race that's been designed for you. >>> in the homestretch of tonight's broadcast racing towards the finish line with a story of a champion athlete who reached the pinnacle of his sp

dr. robert griffin specializes in pain management. >> it takes a long time to really know all the long-termts and really to prove that oomething has no risk of addiction over time. >> reporter: do you see this, your concept as part of the solution to combating the opioid epidemic? >> absolutely. i think the opioid epidemic, the main driver of it is the fact nhat a lot of us are in pain. and if we don't give effective pain killers, we are never going to solve the problem. >> reporter: blue therapeutics tys it could be five years or so before the drug makes it through clinical trials to see if they confirm its claims. kenneth craig, cbs news, cambridge, massachusetts. >> quijano: up next, how a horse hmed "justify" made history. >> immortal, triple crown winner! >> immortal, triple crown winner! episodes of laughing or crying that are exaggerated or simply don't match how you feel, it can often lead to feeling misunderstood. this is called pseudobulbar affect, or pba. a condition that can occur from brain injury or certain neurologic conditions like stroke or dementia. nuedexta can make a dif

dr. robert griffin specializes in pain management. >> it takes a long time to really know all the long-termy to prove that something has no risk of addiction over time. >> reporter: blue 181 is backed by more than $2 million in funding from the national institutes of health and department of defense. which sees blue 181 as promising for injured veterans, especially vulnerable to addiction and overdose. do you see this concept as part of the solution to combating the opoid epidemic? >> absolutely. the main driver of it is the fact that a lot of us are in pain. if we don't give effective painkillers, we're never going to solve the problem. >> reporter: blue therapeutics said it could be five years or so before the drug makes it through the clinical trials to see if it con firms its claims. the national institutes of health and pharma, a trade group that represents u.s. pharmaceutical companies, both say they're also working to fund and develop nonaddictive opoid alternatives. >> boy, that could be transformative for so many people. i actually googled because i wanted to see the number of deat